Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients

Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients

Abstract At the start of the COVID-19 pandemic, the BNT162b2 (BioNTech-Pfizer) and mRNA-1273 (Moderna) mRNA vaccines were expediently designed and mass produced. Both vaccines produce the full-length SARS-CoV-2 spike protein for gain of immunity and have greatly reduced mortality and morbidity from...

Full description

Bibliographic Details
Main Authors: Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, James R. Stone
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-023-00742-7

Similar Items

Similar Items